Search

Your search keyword '"Uwamino, Yoshifumi"' showing total 348 results

Search Constraints

Start Over You searched for: Author "Uwamino, Yoshifumi" Remove constraint Author: "Uwamino, Yoshifumi"
348 results on '"Uwamino, Yoshifumi"'

Search Results

1. Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients

3. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues

8. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022

9. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019–2020: General view of the pathogens' antibacterial susceptibility

10. Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination

11. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections

12. DOCK2 is involved in the host genetics and biology of severe COVID-19

13. Identification of trypsin-degrading commensals in the large intestine

15. Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19

16. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

26. Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic

29. Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan

30. Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals

32. Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells

33. Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences

34. Cost-Effectiveness of Universal Asymptomatic Preoperative Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis

38. Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis

39. Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review

40. Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: A cross-sectional study

44. Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis.

46. Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine

47. Virucidal Effect of the Mesoscopic Structure of CAC-717 on Severe Acute Respiratory Syndrome Coronavirus-2

48. Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review

49. A second update on mapping the human genetic architecture of COVID-19

Catalog

Books, media, physical & digital resources